D
Revolution Medicines, Inc. RVMD
$39.12 $0.090.23%
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

12/31/2024 09/30/2024 06/30/2024 03/31/2024 12/31/2023
Net Income -24.49% -17.30% -14.85% 28.19% -48.97%
Total Depreciation and Amortization 19.79% -0.77% 5.44% -3.71% 38.64%
Total Amortization of Deferred Charges 0.00% 50.00% -33.33% 0.00% 0.00%
Total Other Non-Cash Items -14.08% 80.53% 6,650.47% -100.63% 99.01%
Change in Net Operating Assets 306.42% 318.12% 89.96% -323.17% 874.95%
Cash from Operations -6.04% -1.76% 20.18% -33.18% -19.97%
Capital Expenditure 65.28% -46.73% 24.25% -36.69% 8.60%
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities -2,082.19% -116.27% 145.07% 35.25% -573.27%
Cash from Investing -1,730.09% -119.89% 143.53% 34.81% -591.78%
Total Debt Issued -- -- -- -- --
Total Debt Repaid -- -- -- -- --
Issuance of Common Stock 906.67% 930.04% 826.42% -68.19% 151.83%
Repurchase of Common Stock -- -- -- -- --
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities -- -- -- -- --
Cash from Financing 1,030.50% 930.04% 826.42% -99.90% 82,922.16%
Foreign Exchange rate Adjustments -- -- -- -- --
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash 559.30% -486.48% 96.88% -220.49% 1,628.82%
Weiss Ratings